Analysts Issue Forecasts for RCKT Q1 Earnings
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Rocket Pharmaceuticals in a note issued to investors on Thursday, February 27th. William Blair analyst S. Corwin forecasts that the biotechnology company will post earnings of ($0.27) per share for the quarter. The consensus […]
